Baricitinib
Also sold as: Olumiant
Related Medications
These drugs share a pharmacologic classification but are NOT interchangeable. Listing here does not imply clinical equivalence. A physician must evaluate each drug individually for the patient's specific condition.
Classification: Janus Kinase Inhibitors (source: RxClass/NLM)
- ruxolitinibJanus Kinase InhibitorSame Class
- tofacitinibJanus Kinase InhibitorSame Class
- upadacitinibJanus Kinase InhibitorSame Class
- abrocitinibJanus Kinase InhibitorSame Class
- deucravacitinibJanus Kinase InhibitorSame Class
- deuruxolitinibJanus Kinase InhibitorSame Class
- delgocitinibJanus Kinase InhibitorSame Class
Insurance Coverage User-Reported
No community coverage data yet for baricitinib.
Coverage data submission coming soon.
Drug Information
Detailed drug information (mechanism of action, dosage, warnings, interactions) coming soon.
Verify with Primary Sources
Always verify clinical information with authoritative sources.
Medical Disclaimer: Information on this page is sourced from FDA-approved labeling data and is for educational reference only. It does not constitute medical advice. This information does not establish a provider-patient relationship. Always verify with current prescribing information and consult a licensed healthcare professional before any clinical decision. Read full disclaimer.
Data sourced from RxNorm (NLM/NIH), FDA Orange Book, OpenFDA, DailyMed. Last updated: 2026-03-02.